BIOA – bioage labs, inc. (US:NASDAQ)
Stock Stats
News
BioAge Announces Additional Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor, Demonstrating Potential for Best-in-Class hsCRP Reduction in Participants with Elevated Cardiovascular Risk
BioAge Labs (NASDAQ:BIOA) was downgraded by analysts at Wall Street Zen<
BLA for subcutaneous formulation of Leqembi® accepted in China
2 Reasons I Wouldn't Touch BioAge Labs Stock With a 10-Foot Pole [Yahoo! Finance]
Leqembi included in China's commercial insurance innovative drug list
Form 4 BioAge Labs, Inc. For: Jan 13 Filed by: GOLDSTEIN DOV A MD
Form 4 BioAge Labs, Inc. For: Jan 13 Filed by: Fortney Kristen
Form 144 BioAge Labs, Inc. Filed by: Fortney Kristen
Form 144 BioAge Labs, Inc. Filed by: GOLDSTEIN DOV A MD
Form 8-K BioAge Labs, Inc. For: Jan 12
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.